Phytoestrogens in treatment of climacteric syndrome as an alternative to menopausal hormone therapy

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Here we review Russia-wide and international publications released over the last 5 years dedicated to phytoestrogens used in treatment of climacteric syndrome. Effects of isoflavones as the most examined agents are discussed acting on vasomotor, cognitive, psychological, urogenital and sexual symptoms as well as on the cardiovascular system, bones, and metabolic age-related changes. Despite obtaining controversial data resulting from the analysis, it may be concluded phytoestrogens hold promise as an alternative to menopausal hormone therapy. It is reasonable to conduct further extensive studies to evaluate efficacy and safety of using plant-derived compounds in postmenopausal women.

Cite

CITATION STYLE

APA

Mazitova, M. I., Talipova, I. R., & Mardieva, R. R. (2021). Phytoestrogens in treatment of climacteric syndrome as an alternative to menopausal hormone therapy. Obstetrics, Gynecology and Reproduction, 14(6), 685–693. https://doi.org/10.17749/2313-7347/OB.GYN.REP.2020.175

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free